Form 4: Alkami Technology Director Gary Nelson Acquires Shares

Sentiment:

SEC Form 4 Filing


Director Gary Nelson of Alkami Technology, Inc. acquired 334 shares of common stock on January 5, 2025.

Summary

  • Gary Nelson, a director at Alkami Technology, Inc., acquired 334 shares of common stock on January 5, 2025.
  • The shares were acquired at a price of $0.
  • Following the transaction, Mr. Nelson's total holdings increased to 405,944 shares.

Sentiment

Score: 6

Explanation: The document is a routine filing of a stock acquisition by a director. It is neither particularly positive nor negative, but indicates confidence from a company insider.

Positives

  • The acquisition of shares by a director could be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the transactions of company directors.

Comparison to Industry Standards

  • Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
  • The acquisition of shares by a director is a common occurrence and is not unusual in the context of corporate governance.

Stakeholder Impact

  • The acquisition of shares by a director may be viewed positively by shareholders, indicating confidence in the company's prospects.

Key Dates

DateDescription
01/05/2025Date of the stock acquisition by Gary Nelson.
01/07/2025Date the Form 4 was signed.

Keywords

Alkami Technology, Gary Nelson, stock acquisition, insider trading, Form 4, director, share purchase

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.